Mark Avagliano - Mar 20, 2024 Form 4 Insider Report for G1 Therapeutics, Inc. (GTHX)

Role
Chief Business Officer
Signature
/s / Monica Roberts Thomas, attorney-in-fact
Stock symbol
GTHX
Transactions as of
Mar 20, 2024
Transactions value $
$0
Form type
4
Date filed
3/22/2024, 04:09 PM
Previous filing
Jan 8, 2024
Next filing
May 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GTHX Common Stock Award $0 +100K +84.87% $0.00 218K Mar 20, 2024 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit ("RSU") award that vests 50% on March 20, 2025 and 50% on March 20, 2026, subject to the Reporting Person's continued service through each applicable vesting date.
F2 Each RSU represents a contingent right to receive one share of Issuer common stock.
F3 Represents (i) 13,874 shares of common stock; (ii) 2,750 RSUs from award granted on January 4, 2021; (iii) 6,000 RSUs from award granted on January 3, 2022; (iii) 15,450 RSUs from award granted on January 3, 2023; (iv) 35,000 RSUs from award granted on May 10, 2023; (v) 44,760 RSUs from award granted on January 3, 2024; and (vi) 100,000 RSUs from award granted on March 20, 2024.